News About: Pharm. Industry


15% Advertisement of Health & Special Nutritive Food Judged To Be Inappropriate.

It is disclosed that about 15% advertisement of health supplementary and special nutritive food have not been appropriate during second half of this year. Korea Health Food & Special Nutritive Food Association con...

BIOMEDPARK Regularize Entering Into Overseas Market

Biomedpark, bio venture consortium to develop new medicine regularized their activity to enter into overseas market in collaboration with Dae Han Bio Link. Biomedpark announ...

Functional Food Market Promoting Physical Strength Gathers Attention

Functional food market aiding to promote physical strength that can assist in development of stamina and recovery from fatigue after exercise gathers attention. According to related industry R&D and releasing prod...

Too Difficult Barrier for Bio Venture Firm To List at Kosdaq.

As the registration qualification at Kosdaq got complicated Korean Bio Venture Firms are turning their attention to overseas stock exchange market. According to related industry the registration requisite of Kosdaq...

SK Determined to Attack Chinese Market with BT and IT.

SK Corporation, 4th rank company of Korean economy will reinforce to enter into Chinese market headed with 3 industries including biotechnology. SK China, Chinese Corporation of SK (Representative is Chie Cheng) ...

EPO markets on hot competition.

The product market of EPO (erythropoietin), a genetic recombinant preparation, has been targeted to attack by many major domestic as well as foreign multinational drug corporations. A new once-a-week dosage form of...

Drugs, health foods and bio-venture industries to seek mutual cooperation.

Amid a brisk R&D activity for new functional food stuffs a mutual business collaboration movement shows in shape among the pharmaceutical, health supplement and bio-engineering venture industries. Although the bio-...

China's Joining to WTO Good Opportunity for Korean Company

How will China's joining to WTO affect to Korean Pharmaceutical Industry? As China joined to WTO officially on 10th there is a diversity of opinion about the effect to pharmaceutical industry in Korea in the future...

KPMA Promote to Compose Consortium to Develop New Medicine

KPMA put premise that the corporation model which Korean Pharmaceutical Industry can continue its development is the one progresses fair transaction and the other one with development capability of research and decide...

GSK's Success of Localization Management Attract Attention.

As foreign capital companies with superior product and marketing power making inroads to Korean market created friction with Korean Pharmaceutical Industry due to their exclusive marketing & sales strategy GlaxoSmithK...

TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.